The mechanism of lithium action: State of the art, ten years later

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 25, Issue 4, 2001, Pages 855-866

  Shaldubina, A ^a   Agam, G ^a   Belmaker, R H ^a  

^a MENTAL HEALTH CENTER   (Israel)

Author keywords

3 (2 )phosphoadenosine 5 phosphate; 5HT autoreceptors; Bcl 2; Glutamate; Glycogen synthase kinase 3; Inositol monophosphatase; Lithium

Indexed keywords

ADENOSINE 3' PHOSPHATE 5' PHOSPHOSULFATE; AUTORECEPTOR; GLUTAMIC ACID; GLYCOGEN SYNTHASE KINASE 3; INOSITOL; LITHIUM; NEUROTRANSMITTER; PROTEIN BCL 2; RNA;

AFFECTIVE NEUROSIS; DEGENERATIVE DISEASE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; NONHUMAN; PROPHYLAXIS; REVIEW; RNA PROCESSING; SIGNAL TRANSDUCTION; SYNAPSE;

EID: 0035037851     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(01)00154-3     Document Type: Article

References (41)

1. GSK-3 a new target for lithium's effects in bipolar patients?
2. Reduced brain inositol in lithium treated rats
3. How does lithium work on manic depression? Clinical and psychological correlates of the inositol theory
4. Lithium research: State of the art
5. Phosphoinositides and signal transduction
6. Epi-inositol and inositol depletion: Two new treatment approaches in affective disorder
7. Glycogen synthase kinase-3β facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium
8. Bcl-2 promotes regeneration of severed axons in mammalian CNS
9. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS
10. The mood stabilizing agent Valproate inhibits the activity of Glycogen Synthase Kinase 3
11. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression
12. Inhibition of glycogen synthase kinase 3beta activity regulates proliferation of cultured cerebellar granule cells
13. Lithium addition in treatment-resistant major depression
14. Lithium toxicity in yeast is due to the inhibition of RNA processing enzymes
15. Cellular mechanisms of wingless/Wnt signal transduction
16. Lithium enhances accumulation of [3H] inositol radioactivity and mass of second messenger inositol 1,4,5-trisphosphate in monkey cerebral cortex
17. Lithium stimulates glutamate "release" and inositol 1,4,5-trisphosphate accumulation via activation of the N-methyl-D-aspartate receptor in monkey and mouse cerebral cortex slices
18. Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex
19. Neuroimaging studies of mood disorders
20. A molecular and cellular theory of depression
21. Increased tonic activation of rat forebrain 5-HT(1A) receptors by lithium addition to antidepressant treatments
22. The effect of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain
23. Activation of the Wnt signaling pathway: A molecular mechanism for lithium action
24. Developmental changes in antioxidant enzymes and oxidative damage in kidneys, liver and brain of bcl-2 knockout mice
25. Lithium reduces the accumulation of inositol polyphosphate second messengers following cholinergic stimulation of cerebral cortex slices
26. The importance of 3′-phosphoadenosine 5′-phosphosulphate (PAPS) in the regulaton of sulfation
27. A molecular mechanism for the effect of lithium on development
28. Intracerebroventricular myo-inositol antagonizes lithium-induced suppression of rearing behaviour in rats
29. Lithium increases accumulation of inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate in cholinergically stimulated brain cortex
30. A novel mammalian lithium-sensitive enzyme with a dual enzymatic activity, 3′-phosphoadenosine 5′-phosphate phosphatase and inositol-polyphosphate 1-phosphatase
31. Lithium at 50: Have the neuroprotective effects of this unique cation been overlooked?
32. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: A role for neurotrophic and neuroprotective effects in manic depressive illness
33. 5-HT1B receptors: Anovel target for lithium. Possible involvement in mood disorders
34. Temporal dissociation between lithium-induced CNS myo-inositol changes and clinical response in manic-depressive illness
35. Evidence of the activity of lithium on 5-HT1B receptors in the mouse forced swimming test: Comparison with carbamazepine and sodium valproate
36. Wnt factors in axonal remodelling and synaptogenesis
37. Cloning and characterization of mammalian lithium-sensitive bisphosphate 3′-nucleotidase inhibited by inositol 1,4-bisphosphate
38. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact
39. The role of glycogen synthase kinase 3β in insulin-stimulated glucose metabolism
40. A novel target of lithium therapy
41. GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis